Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12019166rdf:typepubmed:Citationlld:pubmed
pubmed-article:12019166lifeskim:mentionsumls-concept:C0597032lld:lifeskim
pubmed-article:12019166lifeskim:mentionsumls-concept:C0123759lld:lifeskim
pubmed-article:12019166lifeskim:mentionsumls-concept:C0699040lld:lifeskim
pubmed-article:12019166lifeskim:mentionsumls-concept:C0431085lld:lifeskim
pubmed-article:12019166lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:12019166lifeskim:mentionsumls-concept:C0301872lld:lifeskim
pubmed-article:12019166lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:12019166lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:12019166lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:12019166pubmed:issue10lld:pubmed
pubmed-article:12019166pubmed:dateCreated2002-5-20lld:pubmed
pubmed-article:12019166pubmed:abstractTextSystemic or local administration of cytokine has been used as a mode to enhance the antitumor immune response induced by many cancer vaccines. We have investigated whether the expression of cytokines on the tumor cell surface as a glycolipid (GPI)-anchored form will be effective in inducing antitumor immune response using a GPI-anchored interleukin (IL)-12 (GPI-IL-12) as a model. GPI-IL-12-induced the proliferation of concanavalin A-activated T cells and induced IFN-gamma secretion by activated and allogeneic T cells, indicating that the membrane-expressed IL-12 can stimulate T cells. GPI-IL-12 expressed on the tumor cell surface prevented tumor growth in mice in a highly tumorigenic murine mastocytoma model. These results suggest that the cell surface-expressed GPI-IL-12 can be effective in inducing antitumor immune response, and GPI-anchored cytokines expressed on the tumor cell surface may be a novel approach to deliver cytokines at the immunization site during vaccination against cancer. Furthermore, purified GPI-anchored cytokines can be used to quickly modify tumor membranes by the protein transfer method to express the desired cytokines for vaccine development.lld:pubmed
pubmed-article:12019166pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12019166pubmed:languageenglld:pubmed
pubmed-article:12019166pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12019166pubmed:citationSubsetIMlld:pubmed
pubmed-article:12019166pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12019166pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12019166pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12019166pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12019166pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12019166pubmed:statusMEDLINElld:pubmed
pubmed-article:12019166pubmed:monthMaylld:pubmed
pubmed-article:12019166pubmed:issn0008-5472lld:pubmed
pubmed-article:12019166pubmed:authorpubmed-author:NagarajanShan...lld:pubmed
pubmed-article:12019166pubmed:authorpubmed-author:SelvarajPeria...lld:pubmed
pubmed-article:12019166pubmed:issnTypePrintlld:pubmed
pubmed-article:12019166pubmed:day15lld:pubmed
pubmed-article:12019166pubmed:volume62lld:pubmed
pubmed-article:12019166pubmed:ownerNLMlld:pubmed
pubmed-article:12019166pubmed:authorsCompleteYlld:pubmed
pubmed-article:12019166pubmed:pagination2869-74lld:pubmed
pubmed-article:12019166pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:meshHeadingpubmed-meshheading:12019166...lld:pubmed
pubmed-article:12019166pubmed:year2002lld:pubmed
pubmed-article:12019166pubmed:articleTitleGlycolipid-anchored IL-12 expressed on tumor cell surface induces antitumor immune response.lld:pubmed
pubmed-article:12019166pubmed:affiliationDepartment of Pathology and Laboratory Medicine, Emory University School of Medicine, 1639 Pierce Drive, Atlanta, GA 30322, USA.lld:pubmed
pubmed-article:12019166pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12019166pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12019166lld:pubmed